Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The rapid aging of populations in developed countries since the 2000s has placed increasing attention on the issue of musculoskeletal disorders in elderly patients. Notably, spinal disorders not only restrict the social activities of elderly patients, but they also lead to economic loss for society. “Current Advances in Spinal Diseases of Elderly Patients” is a topical collection of articles about current perspectives on diagnosis and treatment of spinal disorders including current surgical strategies. This Special Issue covers a broad range of issues, ranging from managing refractory states such as severe osteoporosis, spinal deformity, ossification of the spinal ligaments, and multiple arthropathy to managing lifestyle-related spinal diseases during the COVID-19 pandemic in elderly populations. We hope that the readers of this Special Issue find the contents interesting.

Medicine --- Pharmacology --- spinal metastasis --- non-small cell lung cancer --- decompression --- survival --- prognosis --- epidermal growth factor receptor --- Uno's C-index --- New England Spinal Metastasis Score --- trunk muscle --- bioelectrical impedance analysis --- MRI --- back muscle strength --- epidemiological study --- osteoporosis --- osteopenia --- locomotive syndrome --- two-step test --- frailty --- cervical myelopathy --- hand grip strength --- falls --- postoperative --- human nonmercaptalbumin --- reduced albumin --- oxidative stress --- spinal sagittal alignment --- low back pain --- health-related quality of life --- conus medullaris --- height --- pelvic incidence --- magnetic resonance imaging --- healthy volunteers --- gender differences --- spine arthrodesis --- spinal fusion --- spine --- deformity --- direct lateral corpectomy --- expandable cage --- global alignment --- local kyphosis --- osteoporosis vertebral fracture --- cervical spine --- clinical findings --- computed tomography --- diffuse idiopathic skeletal hyperostosis --- ossification of the posterior longitudinal ligament --- pain --- patient-reported outcomes --- whole spine --- prevalence --- influence factor --- spinal alignment --- aging --- total knee arthroplasty --- lumbar lordosis --- sagittal spinopelvic parameters --- clinical outcome --- cervical ossification of the posterior longitudinal ligament --- whole-spine computed tomography --- grading system --- multicenter study --- adult spinal deformity (ASD) --- posterior lumbar interbody fusion --- lateral lumbar interbody fusion --- sagittal correction --- perioperative complications --- surgical invasiveness --- degenerative adult deformity --- anterior cervical corpectomy and fusion --- hybrid fusion --- implant failure --- graft subsidence --- complications --- perioperative outcomes --- fusion rate --- segmental paralysis --- mechanical stability --- resident cohort --- resident registry --- spinal balance --- gender --- adult spine --- osteoporotic vertebral fracture --- residual pain --- visual analog scale --- quality of life --- adult spine deformity --- adult spine fusion --- deformity correction --- perioperative parameters --- ODI --- VAS --- disability --- T1 slope --- C2-7 SVA --- C2-7 angle --- back pain --- brace --- spine orthoses --- lumbar support --- spine support --- COVID-19 --- pandemic --- spinal disorder --- elderly --- exercise habit --- female --- activities of daily living --- nutrition --- health checkup data --- full-endoscopic lumbar discectomy --- recurrent herniation --- early recurrence --- spinal metastasis --- non-small cell lung cancer --- decompression --- survival --- prognosis --- epidermal growth factor receptor --- Uno's C-index --- New England Spinal Metastasis Score --- trunk muscle --- bioelectrical impedance analysis --- MRI --- back muscle strength --- epidemiological study --- osteoporosis --- osteopenia --- locomotive syndrome --- two-step test --- frailty --- cervical myelopathy --- hand grip strength --- falls --- postoperative --- human nonmercaptalbumin --- reduced albumin --- oxidative stress --- spinal sagittal alignment --- low back pain --- health-related quality of life --- conus medullaris --- height --- pelvic incidence --- magnetic resonance imaging --- healthy volunteers --- gender differences --- spine arthrodesis --- spinal fusion --- spine --- deformity --- direct lateral corpectomy --- expandable cage --- global alignment --- local kyphosis --- osteoporosis vertebral fracture --- cervical spine --- clinical findings --- computed tomography --- diffuse idiopathic skeletal hyperostosis --- ossification of the posterior longitudinal ligament --- pain --- patient-reported outcomes --- whole spine --- prevalence --- influence factor --- spinal alignment --- aging --- total knee arthroplasty --- lumbar lordosis --- sagittal spinopelvic parameters --- clinical outcome --- cervical ossification of the posterior longitudinal ligament --- whole-spine computed tomography --- grading system --- multicenter study --- adult spinal deformity (ASD) --- posterior lumbar interbody fusion --- lateral lumbar interbody fusion --- sagittal correction --- perioperative complications --- surgical invasiveness --- degenerative adult deformity --- anterior cervical corpectomy and fusion --- hybrid fusion --- implant failure --- graft subsidence --- complications --- perioperative outcomes --- fusion rate --- segmental paralysis --- mechanical stability --- resident cohort --- resident registry --- spinal balance --- gender --- adult spine --- osteoporotic vertebral fracture --- residual pain --- visual analog scale --- quality of life --- adult spine deformity --- adult spine fusion --- deformity correction --- perioperative parameters --- ODI --- VAS --- disability --- T1 slope --- C2-7 SVA --- C2-7 angle --- back pain --- brace --- spine orthoses --- lumbar support --- spine support --- COVID-19 --- pandemic --- spinal disorder --- elderly --- exercise habit --- female --- activities of daily living --- nutrition --- health checkup data --- full-endoscopic lumbar discectomy --- recurrent herniation --- early recurrence

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The rapid aging of populations in developed countries since the 2000s has placed increasing attention on the issue of musculoskeletal disorders in elderly patients. Notably, spinal disorders not only restrict the social activities of elderly patients, but they also lead to economic loss for society. “Current Advances in Spinal Diseases of Elderly Patients” is a topical collection of articles about current perspectives on diagnosis and treatment of spinal disorders including current surgical strategies. This Special Issue covers a broad range of issues, ranging from managing refractory states such as severe osteoporosis, spinal deformity, ossification of the spinal ligaments, and multiple arthropathy to managing lifestyle-related spinal diseases during the COVID-19 pandemic in elderly populations. We hope that the readers of this Special Issue find the contents interesting.

spinal metastasis --- non-small cell lung cancer --- decompression --- survival --- prognosis --- epidermal growth factor receptor --- Uno’s C-index --- New England Spinal Metastasis Score --- trunk muscle --- bioelectrical impedance analysis --- MRI --- back muscle strength --- epidemiological study --- osteoporosis --- osteopenia --- locomotive syndrome --- two-step test --- frailty --- cervical myelopathy --- hand grip strength --- falls --- postoperative --- human nonmercaptalbumin --- reduced albumin --- oxidative stress --- spinal sagittal alignment --- low back pain --- health-related quality of life --- conus medullaris --- height --- pelvic incidence --- magnetic resonance imaging --- healthy volunteers --- n/a --- gender differences --- spine arthrodesis --- spinal fusion --- spine --- deformity --- direct lateral corpectomy --- expandable cage --- global alignment --- local kyphosis --- osteoporosis vertebral fracture --- cervical spine --- clinical findings --- computed tomography --- diffuse idiopathic skeletal hyperostosis --- ossification of the posterior longitudinal ligament --- pain --- patient-reported outcomes --- whole spine --- prevalence --- influence factor --- spinal alignment --- aging --- total knee arthroplasty --- lumbar lordosis --- sagittal spinopelvic parameters --- clinical outcome --- cervical ossification of the posterior longitudinal ligament --- whole-spine computed tomography --- grading system --- multicenter study --- adult spinal deformity (ASD) --- posterior lumbar interbody fusion --- lateral lumbar interbody fusion --- sagittal correction --- perioperative complications --- surgical invasiveness --- degenerative adult deformity --- anterior cervical corpectomy and fusion --- hybrid fusion --- implant failure --- graft subsidence --- complications --- perioperative outcomes --- fusion rate --- segmental paralysis --- mechanical stability --- resident cohort --- resident registry --- spinal balance --- gender --- adult spine --- osteoporotic vertebral fracture --- residual pain --- visual analog scale --- quality of life --- adult spine deformity --- adult spine fusion --- deformity correction --- perioperative parameters --- ODI --- VAS --- disability --- T1 slope --- C2-7 SVA --- C2-7 angle --- back pain --- brace --- spine orthoses --- lumbar support --- spine support --- COVID-19 --- pandemic --- spinal disorder --- elderly --- exercise habit --- female --- activities of daily living --- nutrition --- health checkup data --- full-endoscopic lumbar discectomy --- recurrent herniation --- early recurrence --- Uno's C-index

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored.

Medicine --- malondialdehyde --- oxidative stress --- new-onset diabetes --- renal transplantation --- BK virus --- BK virus nephropathy --- kidney allograft --- transplantation --- Alport syndrome --- children --- autosomal dominant polycystic kidney disease --- epidemiology --- hospitalization --- kidney transplantation --- subarachnoid hemorrhage --- malignancy --- post-transplant malignancy --- renal cell carcinoma --- meta-analysis --- systematic reviews --- tacrolimus --- C/D-ratio --- pharmacokinetics --- opportunistic infection --- allograft survival --- urological complications --- ureteric stent --- urinary tract infection --- timing of removal --- living donor --- ethnicity --- age --- obesity --- genetic relationship donor/recipient --- atypical hemolytic uremic syndrome --- eculizumab --- glucose intolerance --- insulin secretion --- insulin resistance --- oral glucose tolerance test --- healthy subject --- hyperchloremia --- kidney graft dysfunction --- living donor kidney transplantation --- Uropathogenic E. coli --- UPEC --- phylogeny --- genomics --- antibiotic resistance --- virulence traits --- night-time renal transplantation --- graft survival --- patient survival/outcome --- surgical complications --- acute rejection --- lymphocyte --- CD45RC --- Belatacept --- cardiovascular high risk --- outcome --- machine perfusion --- organ preservation --- temperature --- hypothermic --- normothermic --- transplant --- proton-pump inhibitors --- iron --- iron deficiency --- polyomavirus --- BKV --- kidney --- glomerulus --- BKVAN --- nephropathy --- fluid management --- delayed graft function --- goal-directed fluid therapy --- calcineurin inhibitor nephrotoxcity --- C/D ratio --- tacrolimus metabolism --- ADPKD --- native nephrectomy --- patient outcome --- perioperative complications --- epidermal growth factor --- creatinine --- graft failure --- renal transplantation. --- new onset diabetes after renal transplantation --- single nucleotide polymorphisms --- n/a --- urinary biomarkers --- α-GST --- π-GST --- nephrotoxicity --- urinary excretion of N1-methylnicotinamide --- mortality --- niacin status --- dietary intake --- tryptophan --- vitamin B3 --- Kidney transplant --- vitamin C --- cancer mortality --- oxidative stress. --- mycophenolic acid --- immunosuppression --- plasmapheresis --- oxalate --- hyperoxaluria --- kidney transplant recipients --- post-transplantation diabetes mellitus --- all-cause mortality --- cardiovascular mortality --- infectious mortality --- magnesium --- hypomagnesaemia --- cancer --- kidney transplant --- survival --- living kidney donation --- living-donor kidney transplantation --- beliefs --- inequity --- ischemia reperfusion injury --- innate immune system --- adaptive immune system --- apoptosis --- necrosis --- hypoxic inducible factor --- endothelial dysfunction --- proton pump inhibitor --- transplant rejection --- GFR --- insulin-like growth factor 1 --- growth hormone --- muscle mass --- patient survival --- physical activity --- renal transplant recipients --- kidney transplant (KT) --- donor-specific antibodies (DSA) --- C3d-binding assay --- antibody-mediated rejection (AMR) --- arsenic --- diet --- fish consumption --- post-transplant diabetes mellitus --- N1-methyl-2-pyridone-5-carboxamide --- N1-methylnicotinamide --- urinary excretion --- kidney function --- biomarker --- branched chain amino acids --- posttransplant diarrhea --- methanogenesis --- Methanosphaera stadtmanae --- mucins --- sulfate-reducing bacteria --- acute humoral rejection --- first-line therapy --- outcomes --- proteasome inhibitor --- renal transplant --- transplant recipients --- calcineurin inhibitors --- FK506 --- pharmacokinetic --- fast tacrolimus metabolizers

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored.

malondialdehyde --- oxidative stress --- new-onset diabetes --- renal transplantation --- BK virus --- BK virus nephropathy --- kidney allograft --- transplantation --- Alport syndrome --- children --- autosomal dominant polycystic kidney disease --- epidemiology --- hospitalization --- kidney transplantation --- subarachnoid hemorrhage --- malignancy --- post-transplant malignancy --- renal cell carcinoma --- meta-analysis --- systematic reviews --- tacrolimus --- C/D-ratio --- pharmacokinetics --- opportunistic infection --- allograft survival --- urological complications --- ureteric stent --- urinary tract infection --- timing of removal --- living donor --- ethnicity --- age --- obesity --- genetic relationship donor/recipient --- atypical hemolytic uremic syndrome --- eculizumab --- glucose intolerance --- insulin secretion --- insulin resistance --- oral glucose tolerance test --- healthy subject --- hyperchloremia --- kidney graft dysfunction --- living donor kidney transplantation --- Uropathogenic E. coli --- UPEC --- phylogeny --- genomics --- antibiotic resistance --- virulence traits --- night-time renal transplantation --- graft survival --- patient survival/outcome --- surgical complications --- acute rejection --- lymphocyte --- CD45RC --- Belatacept --- cardiovascular high risk --- outcome --- machine perfusion --- organ preservation --- temperature --- hypothermic --- normothermic --- transplant --- proton-pump inhibitors --- iron --- iron deficiency --- polyomavirus --- BKV --- kidney --- glomerulus --- BKVAN --- nephropathy --- fluid management --- delayed graft function --- goal-directed fluid therapy --- calcineurin inhibitor nephrotoxcity --- C/D ratio --- tacrolimus metabolism --- ADPKD --- native nephrectomy --- patient outcome --- perioperative complications --- epidermal growth factor --- creatinine --- graft failure --- renal transplantation. --- new onset diabetes after renal transplantation --- single nucleotide polymorphisms --- n/a --- urinary biomarkers --- α-GST --- π-GST --- nephrotoxicity --- urinary excretion of N1-methylnicotinamide --- mortality --- niacin status --- dietary intake --- tryptophan --- vitamin B3 --- Kidney transplant --- vitamin C --- cancer mortality --- oxidative stress. --- mycophenolic acid --- immunosuppression --- plasmapheresis --- oxalate --- hyperoxaluria --- kidney transplant recipients --- post-transplantation diabetes mellitus --- all-cause mortality --- cardiovascular mortality --- infectious mortality --- magnesium --- hypomagnesaemia --- cancer --- kidney transplant --- survival --- living kidney donation --- living-donor kidney transplantation --- beliefs --- inequity --- ischemia reperfusion injury --- innate immune system --- adaptive immune system --- apoptosis --- necrosis --- hypoxic inducible factor --- endothelial dysfunction --- proton pump inhibitor --- transplant rejection --- GFR --- insulin-like growth factor 1 --- growth hormone --- muscle mass --- patient survival --- physical activity --- renal transplant recipients --- kidney transplant (KT) --- donor-specific antibodies (DSA) --- C3d-binding assay --- antibody-mediated rejection (AMR) --- arsenic --- diet --- fish consumption --- post-transplant diabetes mellitus --- N1-methyl-2-pyridone-5-carboxamide --- N1-methylnicotinamide --- urinary excretion --- kidney function --- biomarker --- branched chain amino acids --- posttransplant diarrhea --- methanogenesis --- Methanosphaera stadtmanae --- mucins --- sulfate-reducing bacteria --- acute humoral rejection --- first-line therapy --- outcomes --- proteasome inhibitor --- renal transplant --- transplant recipients --- calcineurin inhibitors --- FK506 --- pharmacokinetic --- fast tacrolimus metabolizers

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored.

Medicine --- malondialdehyde --- oxidative stress --- new-onset diabetes --- renal transplantation --- BK virus --- BK virus nephropathy --- kidney allograft --- transplantation --- Alport syndrome --- children --- autosomal dominant polycystic kidney disease --- epidemiology --- hospitalization --- kidney transplantation --- subarachnoid hemorrhage --- malignancy --- post-transplant malignancy --- renal cell carcinoma --- meta-analysis --- systematic reviews --- tacrolimus --- C/D-ratio --- pharmacokinetics --- opportunistic infection --- allograft survival --- urological complications --- ureteric stent --- urinary tract infection --- timing of removal --- living donor --- ethnicity --- age --- obesity --- genetic relationship donor/recipient --- atypical hemolytic uremic syndrome --- eculizumab --- glucose intolerance --- insulin secretion --- insulin resistance --- oral glucose tolerance test --- healthy subject --- hyperchloremia --- kidney graft dysfunction --- living donor kidney transplantation --- Uropathogenic E. coli --- UPEC --- phylogeny --- genomics --- antibiotic resistance --- virulence traits --- night-time renal transplantation --- graft survival --- patient survival/outcome --- surgical complications --- acute rejection --- lymphocyte --- CD45RC --- Belatacept --- cardiovascular high risk --- outcome --- machine perfusion --- organ preservation --- temperature --- hypothermic --- normothermic --- transplant --- proton-pump inhibitors --- iron --- iron deficiency --- polyomavirus --- BKV --- kidney --- glomerulus --- BKVAN --- nephropathy --- fluid management --- delayed graft function --- goal-directed fluid therapy --- calcineurin inhibitor nephrotoxcity --- C/D ratio --- tacrolimus metabolism --- ADPKD --- native nephrectomy --- patient outcome --- perioperative complications --- epidermal growth factor --- creatinine --- graft failure --- renal transplantation. --- new onset diabetes after renal transplantation --- single nucleotide polymorphisms --- urinary biomarkers --- α-GST --- π-GST --- nephrotoxicity --- urinary excretion of N1-methylnicotinamide --- mortality --- niacin status --- dietary intake --- tryptophan --- vitamin B3 --- Kidney transplant --- vitamin C --- cancer mortality --- oxidative stress. --- mycophenolic acid --- immunosuppression --- plasmapheresis --- oxalate --- hyperoxaluria --- kidney transplant recipients --- post-transplantation diabetes mellitus --- all-cause mortality --- cardiovascular mortality --- infectious mortality --- magnesium --- hypomagnesaemia --- cancer --- kidney transplant --- survival --- living kidney donation --- living-donor kidney transplantation --- beliefs --- inequity --- ischemia reperfusion injury --- innate immune system --- adaptive immune system --- apoptosis --- necrosis --- hypoxic inducible factor --- endothelial dysfunction --- proton pump inhibitor --- transplant rejection --- GFR --- insulin-like growth factor 1 --- growth hormone --- muscle mass --- patient survival --- physical activity --- renal transplant recipients --- kidney transplant (KT) --- donor-specific antibodies (DSA) --- C3d-binding assay --- antibody-mediated rejection (AMR) --- arsenic --- diet --- fish consumption --- post-transplant diabetes mellitus --- N1-methyl-2-pyridone-5-carboxamide --- N1-methylnicotinamide --- urinary excretion --- kidney function --- biomarker --- branched chain amino acids --- posttransplant diarrhea --- methanogenesis --- Methanosphaera stadtmanae --- mucins --- sulfate-reducing bacteria --- acute humoral rejection --- first-line therapy --- outcomes --- proteasome inhibitor --- renal transplant --- transplant recipients --- calcineurin inhibitors --- FK506 --- pharmacokinetic --- fast tacrolimus metabolizers --- malondialdehyde --- oxidative stress --- new-onset diabetes --- renal transplantation --- BK virus --- BK virus nephropathy --- kidney allograft --- transplantation --- Alport syndrome --- children --- autosomal dominant polycystic kidney disease --- epidemiology --- hospitalization --- kidney transplantation --- subarachnoid hemorrhage --- malignancy --- post-transplant malignancy --- renal cell carcinoma --- meta-analysis --- systematic reviews --- tacrolimus --- C/D-ratio --- pharmacokinetics --- opportunistic infection --- allograft survival --- urological complications --- ureteric stent --- urinary tract infection --- timing of removal --- living donor --- ethnicity --- age --- obesity --- genetic relationship donor/recipient --- atypical hemolytic uremic syndrome --- eculizumab --- glucose intolerance --- insulin secretion --- insulin resistance --- oral glucose tolerance test --- healthy subject --- hyperchloremia --- kidney graft dysfunction --- living donor kidney transplantation --- Uropathogenic E. coli --- UPEC --- phylogeny --- genomics --- antibiotic resistance --- virulence traits --- night-time renal transplantation --- graft survival --- patient survival/outcome --- surgical complications --- acute rejection --- lymphocyte --- CD45RC --- Belatacept --- cardiovascular high risk --- outcome --- machine perfusion --- organ preservation --- temperature --- hypothermic --- normothermic --- transplant --- proton-pump inhibitors --- iron --- iron deficiency --- polyomavirus --- BKV --- kidney --- glomerulus --- BKVAN --- nephropathy --- fluid management --- delayed graft function --- goal-directed fluid therapy --- calcineurin inhibitor nephrotoxcity --- C/D ratio --- tacrolimus metabolism --- ADPKD --- native nephrectomy --- patient outcome --- perioperative complications --- epidermal growth factor --- creatinine --- graft failure --- renal transplantation. --- new onset diabetes after renal transplantation --- single nucleotide polymorphisms --- urinary biomarkers --- α-GST --- π-GST --- nephrotoxicity --- urinary excretion of N1-methylnicotinamide --- mortality --- niacin status --- dietary intake --- tryptophan --- vitamin B3 --- Kidney transplant --- vitamin C --- cancer mortality --- oxidative stress. --- mycophenolic acid --- immunosuppression --- plasmapheresis --- oxalate --- hyperoxaluria --- kidney transplant recipients --- post-transplantation diabetes mellitus --- all-cause mortality --- cardiovascular mortality --- infectious mortality --- magnesium --- hypomagnesaemia --- cancer --- kidney transplant --- survival --- living kidney donation --- living-donor kidney transplantation --- beliefs --- inequity --- ischemia reperfusion injury --- innate immune system --- adaptive immune system --- apoptosis --- necrosis --- hypoxic inducible factor --- endothelial dysfunction --- proton pump inhibitor --- transplant rejection --- GFR --- insulin-like growth factor 1 --- growth hormone --- muscle mass --- patient survival --- physical activity --- renal transplant recipients --- kidney transplant (KT) --- donor-specific antibodies (DSA) --- C3d-binding assay --- antibody-mediated rejection (AMR) --- arsenic --- diet --- fish consumption --- post-transplant diabetes mellitus --- N1-methyl-2-pyridone-5-carboxamide --- N1-methylnicotinamide --- urinary excretion --- kidney function --- biomarker --- branched chain amino acids --- posttransplant diarrhea --- methanogenesis --- Methanosphaera stadtmanae --- mucins --- sulfate-reducing bacteria --- acute humoral rejection --- first-line therapy --- outcomes --- proteasome inhibitor --- renal transplant --- transplant recipients --- calcineurin inhibitors --- FK506 --- pharmacokinetic --- fast tacrolimus metabolizers